Degradation of bovine cartilage proteoglycan in vitro is enhanced by inhibition of nitric oxide synthase.
Department of Inflammation and Autoimmune Diseases, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA.
A C
AC
Hanglow
K
K
Rowan
L
L
Lusch
J W
JW
Coffey
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002356:Cartilage / Q000378:metabolism*; D002417:Cattle; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006025:Glycosaminoglycans / Q000378:metabolism; D066298:In Vitro Techniques; D007202:Indicators and Reagents; D007375:Interleukin-1 / Q000494:pharmacology; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D011509:Proteoglycans / Q000378:metabolism*; D013876:Thiophenes / Q000494:pharmacology; D019323:omega-N-Methylarginine
D004791:Enzyme Inhibitors; D006025:Glycosaminoglycans; D007202:Indicators and Reagents; D007375:Interleukin-1; D011480:Protease Inhibitors; D011509:Proteoglycans; D013876:Thiophenes; D019323:omega-N-Methylarginine; D010649:Phenylalanine; D001120:Arginine; C080985:batimastat; D019001:Nitric Oxide Synthase; D008666:Metalloendopeptidases